CareCloud Momentum Continues with New Clients, Partners and Platform Integrations in First Fiscal Quarter 2019

MIAMI–(BUSINESS WIRE)–#EHR–CareCloud, the platform for high-growth medical groups, today provided a
quarterly update on the company’s modern enterprise cloud platform.

“We’ve invested heavily in building the technology infrastructure that
medical groups need to grow in an increasingly complex healthcare
environment,” said Ken Comée, CareCloud CEO. “It’s exciting to see
clients embrace the advanced technology we’re bringing to market and to
see the remarkable impact it is having on their businesses.”

Among the results achieved in the first quarter of 2019:

Platform Integrations

Leading indicators show that medical groups are leveraging CareCloud’s
open API in many new ways to support their strategies for patient health
outcomes and practice growth.

  • Reached a new record number of daily API calls with over 2.15 million
    calls per day, representing a 20 percent increase from just 6 months
    ago.
  • Welcomed PatientPop
    and LumaHealth
    to the CareCloud partnership program to make these innovative
    technologies available to medical group clients.
  • Saw the highest ever share of clients (27 percent) using at least one
    partner to extend the capabilities of the CareCloud platform to
    support their practice.
  • Integrated the first ever client-developed
    app
    with CareCloud Charts.

“I developed CareCloud Schedule as a companion app to our CareCloud EHR
to better visualize my clinic schedule from any location,” said Reid
Wainess, MD, Partner, Acuity Eye Group. “CareCloud has made it
incredibly easy for clinician developers like myself to integrate our
apps with their platform and I’d encourage others with a great idea to
give it a try.”

Client Performance

CareCloud reached new performance milestones in support of a rapidly
growing client base of medical groups utilizing the company’s electronic
health record, patient experience, practice management and revenue cycle
management technology.

  • Welcomed nearly 400 new providers to one or more CareCloud solutions.
  • Processed the most claims on a quarterly basis in the company’s
    history at 3.4 million.
  • Billed the highest amount of total claims within a single quarter on
    behalf of revenue cycle management clients at $420 million.
  • Achieved a First Pass No Response Rate of 1.0%, a company all-time
    best and critical indicator for the speed of claims submission and
    payment remittance.

To learn more about CareCloud or to become a development partner, visit
carecloud.com or send a message to hello@carecloud.com.

About CareCloud

CareCloud is the leading provider of cloud-based revenue cycle
management, practice management (PM), electronic health record (EHR),
patient experience management (PXM), and telemedicine solutions for
high-growth medical groups. CareCloud helps clients increase
profitability, streamline workflow and improve patient care nationwide.
The company currently manages more than $4.5 billion in annualized
accounts receivable on its integrated clinical and financial platform.
To learn more about CareCloud, visit www.carecloud.com.

Contacts

Lynn Shepherd
lshepherd@carecloud.com
610.613.7263

Staff

Recent Posts

Bemax Announces Financial Results for Fiscal Fourth Quarter Ended May 31, 2024

- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…

1 hour ago

1933 Industries Reports Profit in Q3 2024 Financials

VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…

1 hour ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…

1 hour ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…

1 hour ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…

1 hour ago